Product
Intradermal BCG SSI
1 clinical trial
2 indications
Indication
BCG vaccination reactionIndication
TuberculosisClinical trial
A Multi-national, Multi-center, Randomized, Double-Blind, Active-Controlled, Phase III Study to Investigate the Efficacy and Safety of 'GC3107(BCG Vaccine)' After Intradermal Administration in Healthy InfantsStatus: Completed, Estimated PCD: 2022-06-20